Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 1/2018

01-02-2018 | Review Article

Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?

Authors: Mohammed A. Mohammed, Rebekah J. Moles, Timothy F. Chen

Published in: International Journal of Clinical Pharmacy | Issue 1/2018

Login to get access

Abstract

Background Several measures of Health-Related Quality of Life (HRQoL) have been used to evaluate Pharmaceutical Care (PC) interventions in the past decades. However, their suitability for evaluation of PC services has not been comprehensively evaluated. Aim of the review The aim of this review was to perform content analysis of HRQoL measures used in PC studies to gain an insight into their suitability for evaluation of PC services. Method PC studies evaluating HRQoL as a primary or secondary outcomes were retrieved based on a literature search of articles published from 1990 to 2015, on Medline, Embase, International Pharmaceutical Abstracts, Global Health, PsycInfo, Web of Science, Cinahl, HealthStar, Cochrane Library, AUSThealth, Australian Medical Index, and Current content. Measures of HRQoL used in the studies were identified and relevant information was extracted. A conceptual model of a patient reported Medication-Related Burden Quality of Life was used to guide the analysis. Results 117 studies were retrieved. Thirty-seven: 10 generic, 27 condition-specific HRQoL measures with a total of 1019 items about physical functioning (n = 430), psychological wellbeing (n = 288), social wellbeing (n = 119), physical burden (n = 69) and others (n = 113) were used in the studies. Only 34 of 1019 items were specifically related to medicines. Of these, the majority of items focused on other aspects of medicine such as adherence, rather than the burden imposed by medicine on quality of life. Conclusion A holistic analysis of HRQoL measures used in PC studies published over two and half decades provided a better insight into sensitivity and specificity of the measures to PC services. This review found that HRQoL measures used in PC studies provide a very limited coverage of themes related to the burden of medicine on quality of life. Therefore, may have limited potential for use as a sole humanistic measure when evaluating PC interventions. There is a scope for future research in the development of an alternative measure suitable for evaluation of the burden of medicine and the impact of PC interventions on quality of life outcomes.
Appendix
Available only for authorised users
Literature
1.
Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6(2):e010035.CrossRefPubMedPubMedCentral
2.
Sav A, King MA, Whitty JA, Kendall E, McMillan SS, Kelly F. Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect. 2015;18(3):312–24.CrossRefPubMed
3.
Tran V-T, Barnes C, Montori VM, Falissard B, Ravaud P. Taxonomy of the burden of treatment: a multi-country web-based qualitative study of patients with chronic conditions. BMC Med. 2015;13(1):1–15.CrossRef
4.
Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.CrossRefPubMed
5.
Murawski MM, Bentley JP. Pharmaceutical therapy-related quality of life: conceptual development. J Soc Adm Pharm. 2001;18(1):2–14.
6.
Loonen HJ, Derkx BH, Otley AR. Measuring health-related quality of life of pediatric patients. J Pediatr Gastroenterol Nutr. 2001;32(5):523–6.CrossRefPubMed
7.
Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 1992;45(7):743–60.CrossRefPubMed
8.
Rapkin BD, Schwartz CE. Toward a theoretical model of quality-of-life appraisal: implications of findings from studies of response shift. Health Qual Life Outcomes. 2004;2:14.CrossRefPubMedPubMedCentral
9.
Petersson C, Simeonsson RJ, Enskar K, Huus K. Comparing children’s self-report instruments for health-related quality of life using the international classification of functioning, disability and health for children and youth (ICF-CY). Health Qual Life Outcomes. 2013;11:75.CrossRefPubMedPubMedCentral
10.
11.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622–9.CrossRefPubMed
12.
Carlton J, Kaltenthaler E. Health-related quality of life measures (HRQoL) in patients with amblyopia and strabismus: a systematic review. Br J Ophthalmol. 2011;95(3):325–30.CrossRefPubMed
13.
Mohammed MA, Moles RJ, Chen TF. Impact of pharmaceutical care interventions on health-related quality-of-life outcomes: a systematic review and meta-analysis. Ann Pharmacother. 2016;50(10):862–81.CrossRefPubMed
14.
Pickard AS, Hung S-Y. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann Pharmacother. 2006;40(9):1623–34.CrossRefPubMed
15.
Pickard AS, Johnson JA, Farris KB. The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother. 1999;33(11):1167–72.CrossRefPubMed
16.
Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. Int J of Pharm Pract. 2005;13(1):53–70.CrossRef
17.
Quittner AL, Modi A, Cruz I. Systematic review of health-related quality of life measures for children with respiratory conditions. Paediatr Respir Rev. 2008;9(3):220–32.CrossRefPubMed
18.
Kheir NM, van Mil JW, Shaw JP, Sheridan JL. Health-related quality of life measurement in pharmaceutical care. Targeting an outcome that matters. Pharm World Sci. 2004;26(3):125–8.CrossRefPubMed
19.
Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol. 1992;45(5):461–72.CrossRefPubMed
20.
Christie MJ, French D, Sowden A, West A. Development of child-centered disease-specific questionnaires for living with asthma. Psychosom Med. 1993;55(6):541–8.CrossRefPubMed
21.
Burroughs TE, Desikan R, Waterman BM, Gilin D, McGill J. Development and validation of the diabetes quality of life brief clinical inventory. Diabetes Spectr. 2004;17(1):41–9.CrossRef
22.
Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg. 1995;82(2):216–22.CrossRefPubMed
23.
Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76–83.CrossRefPubMedPubMedCentral
24.
Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res. 1991;35(1):99–110.CrossRefPubMed
25.
Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321–6.PubMed
26.
Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 1998;39(1):81–8.CrossRefPubMed
27.
Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med. 1991;85:25–31.CrossRefPubMed
28.
Wan C, Meng Q, Yang Z, Tu X, Feng C, Tang X, et al. Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Ann Oncol. 2008;19(12):2053–60.CrossRefPubMedPubMedCentral
29.
Wan C, Yang Z, Meng Q, Feng C, Wang H, Tang X, et al. Development and validation of the general module of the system of quality of life instruments for cancer patients. Int J Cancer. 2008;122(1):190–6.CrossRefPubMed
30.
Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM, Solomon DK, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998;38(5):586–97.CrossRef
31.
Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health. 1980;34(4):281–6.CrossRefPubMedPubMedCentral
32.
33.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.CrossRefPubMed
34.
Rector TS, Kubo SH, Cohn JN. Patients’ selfassessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Fail. 1987;3:198–209.
35.
Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 1999;281(2):145–50.CrossRefPubMed
36.
Salek SS. Quality of life in patients with end-stage renal disease. J Appl Ther. 1999;2:163–70.
37.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.PubMed
38.
Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.CrossRefPubMedPubMedCentral
39.
Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, et al. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European foundation for osteoporosis. Osteoporos Int. 1997;7(1):36–8.CrossRefPubMed
40.
Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The henry ford hospital headache disability inventory (HDI). Neurology. 1994;44(5):837–42.CrossRefPubMed
41.
42.
Bentsen BG, Natvig B, Winnem M. Questions you didn’t ask? COOP/WONCA charts in clinical work and research. World Organization of Colleges, Academies and Academic Associations of General Practitioners/Family Physicists. Fam Pract. 1999;16(2):190–5.CrossRefPubMed
43.
Gaston JE, Vogl L. Psychometric properties of the general well-being index. Qual Life Res. 2005;14(1):71–5.CrossRefPubMed
44.
Olufade AO, Shaw JW, Foster SA, Leischow SJ, Hays RD, Coons SJ. Development of the Smoking Cessation Quality of Life questionnaire. Clin Ther. 1999;21(12):2113–30.CrossRefPubMed
45.
Goodman M, Hull JW, Terkelsen KG, Smith TE, Anthony D. Factor structure of quality of life: the Lehman interview. Eval Program Plan. 1997;20(4):477–80.CrossRef
46.
Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plan. 1988;11(1):51–62.CrossRef
47.
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form parkinson’s disease questionnaire. Psychol Health. 1997;12(6):805–14.CrossRef
48.
Kopec JA, Sayre EC, Davis AM, Badley EM, Abrahamowicz M, Pouchot J, et al. Development of a paper-and-pencil semi-adaptive questionnaire for 5 domains of health-related quality of life (PAT-5D-QOL). Qual Life Res. 2013;22(10):2829–42.CrossRefPubMed
49.
Binkley JM, Stratford PW, Lott SA, Riddle DL. The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. North American orthopaedic rehabilitation research network. Phys Ther. 1999;79(4):371–83.PubMed
50.
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.CrossRefPubMed
51.
Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8(1–2):79–91.CrossRefPubMed
52.
53.
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.CrossRefPubMed
54.
Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996;5(1):35–46.CrossRefPubMed
55.
Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–28.CrossRefPubMed
56.
Guyatt GH, Nogradi S, Halcrow S, Singer J, Sullivan MJ, Fallen EL. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med. 1989;4(2):101–7.CrossRefPubMed
57.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998.
58.
Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care. 2001;39(2):113–22.CrossRefPubMed
59.
Loh ZWR, Cheen MHH, Wee HL. Humanistic and economic outcomes of pharmacist-provided medication review in the community-dwelling elderly: a systematic review and meta-analysis. J Clin Pharm Ther. 2016;41(6):621–33.CrossRefPubMed
60.
Kjeldsen LJ, Nielsen TR, Olesen C. The challenges of outcome research. Int J Clin Pharm. 2016;38(3):705–8.PubMed
61.
Krska J, Rowe PH. Outcome measures: a sensitive approach. Int J Pharm Pract. 2010;18(2):125–7.PubMed
62.
Sakthong P, Suksanga P, Sakulbumrungsil R, Winit-Watjana W. Development of patient-reported outcomes measure of pharmaceutical therapy for quality of life (PROMPT-QoL): a novel instrument for medication management. Res Soc Adm Pharm. 2015;11(3):315–38.CrossRef
63.
Tseng HM, Lee CH, Chen YJ, Hsu HH, Huang LY, Huang JL. Developing a measure of medication-related quality of life for people with polypharmacy. Qual Life Res. 2016;25(5):1295–302.CrossRefPubMed
64.
Cohen LL, La Greca AM, Blount RL, Kazak AE, Holmbeck GN, Lemanek KL. Introduction to special issue: evidence-based assessment in pediatric psychology. J Pediatr Psychol. 2008;33(9):911–5.CrossRefPubMed
65.
Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10:22.CrossRefPubMedPubMedCentral
66.
Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651–7.CrossRefPubMed
Metadata
Title
Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?
Authors
Mohammed A. Mohammed
Rebekah J. Moles
Timothy F. Chen
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0582-8

Other articles of this Issue 1/2018

International Journal of Clinical Pharmacy 1/2018 Go to the issue

Research Article

Practice of community pharmacists related to multivitamin supplements: a simulated patient study in Iran

Short Research Report

Implementing a screening tool to improve prescribing in hospitalized older patients: a pilot study

Research Article

Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan

Research Article

Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes and knowledge

Research Article

The quality of information on the internet relating to top-selling dietary supplements in the Czech Republic

Research Article

Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits